120Chapter 723. Sydorak RM, Nijagal A, Sbragia L, HiroseS, Tsao K, Phibbs RH, et al:Gastroschisis: small hole, big cost. JPediatr Surg 2002; 37(12): 1669-1672.24. <strong>Poley</strong> MJ, Stolk EA, Langemeijer RATM,Molenaar JC, Busschbach JJV: The costeffectivenessof neonatal surgery andsubsequent treatment for congenitalanorectal malformations. J Pediatr Surg2001; 36(10): 1471-1478.25. <strong>Poley</strong> MJ, Stolk EA, Tibboel D, MolenaarJC, Busschbach JJV: The costeffectivenessof treatment for congenitaldiaphragmatic hernia. J Pediatr Surg2002; 37(9): 1245-1252.26. <strong>Poley</strong> MJ, Stolk EA, Tibboel D, MolenaarJC, Busschbach JJV: Short term and longterm health related quality of life aftercongenital anorectal malformations andcongenital diaphragmatic hernia. ArchDis Child 2004; 89(9): 836-841.27. Devlin N, Parkin D: Does NICE have acost-effectiveness threshold and whatother factors influence its decisions? Abinary choice analysis. Health Econ2004; 13(5): 437-452.28. George B, Harris A, Mitchell A: Costeffectivenessanalysis and theconsistency of decision making:evidence from pharmaceuticalreimbursement in Australia (1991 to1996). Pharmacoeconomics 2001;19(11): 1103-1109.29. Simoons ML, Casparie AF: Therapy andprevention of coronary heart diseasesthrough lowering of the serumcholesterol levels; third consensus'Cholesterol' [in Dutch]. Ned TijdschrGeneeskd 1998; 142(38): 2096-2101.30. Ravitch MM, Barton BA: The need forpediatric surgeons as determined by thevolume of work and the mode of deliveryof surgical care. Surgery 1974; 76(5):754-763.31. Caniano DA: Ethical issues in themanagement of neonatal surgicalanomalies. Semin Perinatol 2004; 28(3):240-245.32. Molenaar JC: Ethics in pediatric surgery.Eur J Pediatr Surg 1996; 6(3): 132-135.33. Saal HM: Neonatal intensive care as alocus for ethical decisions. Cleft PalateCraniofac J 1995; 32(6): 500-503.34. Hilhorst MT: The ethical assessment ofnew technologies: the case of ECMO. InMisbin RI, Jennings B, Orentlicher D,Dewar M (eds): Health care crisis? Thesearch for answers. Frederick, Maryland:University Publishing Group; 1995.35. Hussain N, Rosenkrantz TS: Ethicalconsiderations in the management ofinfants born at extremely low gestationalage. Semin Perinatol 2003; 27(6): 458-470.36. Simeoni U, Vendemmia M, Rizzotti A,Gamerre M: Ethical dilemmas in extremeprematurity: recent answers; morequestions. Eur J Obstet Gynecol ReprodBiol 2004; 117(Suppl 1): S33-S36.37. Flake AW: Prenatal intervention: ethicalconsiderations for life-threatening andnon-life-threatening anomalies. SeminPediatr Surg 2001; 10(4): 212-221.38. Howe EG: Ethical issues in fetal surgery.Semin Perinatol 2003; 27(6): 446-457.39. Van Howe RS, Svoboda JS, Dwyer JG,Price CP: Involuntary circumcision: thelegal issues. BJU Int 1999; 83 Suppl 1:63-73.40. Petrou S, Edwards L: Cost effectivenessanalysis of neonatal extracorporealmembrane oxygenation based on fouryear results from the UK CollaborativeECMO Trial. Arch Dis Child FetalNeonatal Ed 2004; 89(3): F263-F268.41. Lantos JD: Hooked on neonatology. Apediatrician wonders about NICU'shidden cost of success. Health Aff(Millwood) 2001; 20(5): 233-240.42. Loewy RS: Ageisms. Health Care Anal2005; 13(2): 147-156.43. Bleichrodt H, Diecidue E, Quiggin J:Equity weights in the allocation of healthcare: the rank-dependent QALY model. JHealth Econ 2004; 23(1): 157-171.
Cost-Effectiveness of Neonatal Surgery: First Skepticized, Now Increasingly Accepted 12144. Johannesson M, Gerdtham UG: A noteon the estimation of the equity-efficiencytrade-off for QALYs. J Health Econ 1996;15(3): 359-368.45. Lindholm L, Rosén M, Emmelin M: Anepidemiological approach towardsmeasuring the trade-off between equityand efficiency in health policy. HealthPolicy 1996; 35(3): 205-216.46. Stolk EA, Donselaar Gv, Brouwer WBF,Busschbach JJV: Reconciliation ofeconomic concerns and health policy:illustration of an equity adjustmentprocedure using proportional shortfall.Pharmacoeconomics 2004; 22(17):1097-1107.47. Wagstaff A: QALYs and the equityefficiencytrade-off. J Health Econ 1991;10(1): 21-41.48. Williams A: Intergenerational equity: anexploration of the 'fair innings'argument. Health Econ 1997; 6(2): 117-132.49. Williams A: Inequalities in health andintergenerational equity. Ethical TheoryMoral Pract 1999; 2(1): 47-55.50. Busschbach JJV, Hessing DJ, Charro FTd:The utility of health at different stages inlife: a quantitative approach. Soc SciMed 1993; 37(2): 153-158.51. Charny MC, Lewis PA, Farrow SC:Choosing who shall not be treated in theNHS. Soc Sci Med 1989; 28(12): 1331-1338.52. Johannesson M, Johansson PO: Is thevaluation of a QALY gained independentof age? Some empirical evidence. JHealth Econ 1997; 16(5): 589-599.53. Lewis PA, Charny M: Which of twoindividuals do you treat when only theirages are different and you can't treatboth? J Med Ethics 1989; 15(1): 28-32.54. Nord E, Richardson J, Street A, Kuhse H,Singer P: Maximizing health benefits vsegalitarianism: an Australian survey ofhealth issues. Soc Sci Med 1995;41(10): 1429-1437.55. Nord E, Street A, Richardson J, Kuhse H,Singer P: The significance of age andduration of effect in social evaluation ofhealth care. Health Care Anal 1996;4(2): 103-111.56. World Bank: World development report1993: investing in health. Washington,DC: World Bank; 1993.57. Jonsen AR: Bentham in a box:technology assessment and health careallocation. Law, Medicine & Health Care1986; 14(3-4): 172-174.58. Nord E: The trade-off between severityof illness and treatment effect in costvalueanalysis of health care. HealthPolicy 1993; 24(3): 227-238.59. Nord E, Pinto JL, Richardson J, Menzel P,Ubel P: Incorporating societal concernsfor fairness in numerical valuations ofhealth programmes. Health Econ 1999;8(1): 25-39.60. Pinto Prades JL: Is the person trade-off avalid method for allocating health careresources? Health Econ 1997; 6(1): 71-81.61. Ubel PA, Loewenstein G, Scanlon D,Kamlet M: Individual utilities areinconsistent with rationing choices: apartial explanation of why Oregon's costeffectivenesslist failed. Med DecisMaking 1996; 16(2): 108-116.62. <strong>Poley</strong> MJ, Stolk EA, Brouwer WBF,Busschbach JJV: 'Necessity' determinedon the basis of disease severity whenprioritising health care interventions [inDutch]. Ned Tijdschr Geneeskd 2002;146(48): 2312-2315.63. Nord E: An alternative to QALYs: thesaved young life equivalent (SAVE). BrMed J 1992; 305(6858): 875-877.64. Barr RD, Chalmers D, Pauw Sd, FurlongW, Weitzman S, Feeny D: Health-relatedquality of life in survivors of Wilms'tumor and advanced neuroblastoma: across-sectional study. J Clin Oncol 2000;18(18): 3280-3287.
- Page 3:
COST-EFFECTIVENESS OF NEONATAL SURG
- Page 6 and 7:
DOCTORAL COMMITTEEPromotors:Prof.dr
- Page 9 and 10:
PUBLICATIONSChapters 2 to 7 are bas
- Page 11:
6ChapterINFORMAL CARE FOR CHILDREN
- Page 14 and 15:
2Chapter 11.1 BACKGROUND AND MOTIVA
- Page 16 and 17:
4Chapter 1provides a good overview
- Page 18 and 19:
6Chapter 1disability, and death of
- Page 21:
Introduction 9particular equity pri
- Page 25 and 26:
Introduction 1320. Oostenbrink JB,
- Page 27 and 28:
Introduction 1554. Heyman MB, Harma
- Page 29 and 30:
THE COST-EFFECTIVENESS OFTREATMENT
- Page 31:
Cost-Effectiveness of Treatment for
- Page 35 and 36:
Cost-Effectiveness of Treatment for
- Page 37 and 38:
Cost-Effectiveness of Treatment for
- Page 39 and 40:
Cost-Effectiveness of Treatment for
- Page 41 and 42:
Cost-Effectiveness of Treatment for
- Page 43 and 44:
Cost-Effectiveness of Treatment for
- Page 45:
Cost-Effectiveness of Treatment for
- Page 48 and 49:
36Chapter 3ABSTRACTBackground/Purpo
- Page 50 and 51:
38Chapter 33.2 MATERIALS AND METHOD
- Page 52 and 53:
40Chapter 3child's date of birth) a
- Page 54 and 55:
42Chapter 3diaphragm was closed (Ta
- Page 56 and 57:
44Chapter 3Total costs of treatment
- Page 58 and 59:
46Chapter 3Regarding the treatment
- Page 60 and 61:
48Chapter 3REFERENCES1. Stolk EA, P
- Page 62 and 63:
50Chapter 332. Jaillard S, Pierrat
- Page 64 and 65:
52Chapter 4ABSTRACTAims:To examine
- Page 66 and 67:
54Chapter 4Outcome measuresThe pati
- Page 68 and 69:
56Chapter 4Clearly, the symptoms st
- Page 70 and 71:
58Chapter 4The respondents did not
- Page 72 and 73:
60Chapter 4Table 4.4TAIQOL Scores o
- Page 74 and 75:
62Chapter 44.4 DISCUSSIONIn this pa
- Page 76 and 77:
64Chapter 4ACKNOWLEDGMENTSWe are in
- Page 78 and 79:
66Chapter 418. Coons SJ, Rao S, Kei
- Page 80 and 81:
68Chapter 5ABSTRACTObjective:Extrac
- Page 82 and 83: 70Chapter 5treatment. 26,27 Finally
- Page 84 and 85: 72Chapter 5CostsOnly direct costs w
- Page 86 and 87: 74Chapter 5summarized in Table 5.2.
- Page 88 and 89: 76Chapter 5Table 5.3 Direct Medical
- Page 90 and 91: 78Chapter 5Figure 5.3 illustrates o
- Page 92 and 93: 80Chapter 5severely ill newborns—
- Page 94 and 95: 82Chapter 5REFERENCES1. Bartlett RH
- Page 96 and 97: 84Chapter 533. Meinert CL: Extracor
- Page 98 and 99: 86Chapter 568. Hui TT, Danielson PD
- Page 100 and 101: 88Chapter 6ABSTRACTObjective:To inv
- Page 102 and 103: 90Chapter 6a rule. The health-relat
- Page 104 and 105: 92Chapter 6Regression analysis of h
- Page 106 and 107: 94Chapter 6that caregiving for thei
- Page 108 and 109: 96Chapter 6Table 6.5 CareQol Compar
- Page 110 and 111: 98Chapter 6children with a disabili
- Page 112 and 113: 100Chapter 6This study was of impor
- Page 114 and 115: 102Chapter 618. Poley MJ, Stolk EA,
- Page 116 and 117: 104Chapter 654. Boman KK, Viksten J
- Page 118 and 119: 106Chapter 7ABSTRACTMortality rates
- Page 120 and 121: 108Chapter 77.2 THE RELEVANCE OF CO
- Page 122 and 123: 110Chapter 7In the early 2000s, our
- Page 124 and 125: 112Chapter 7Table 7.1 Economic Eval
- Page 126 and 127: 114Chapter 7More from a policy pers
- Page 128 and 129: 116Chapter 7also expect that life-s
- Page 130 and 131: 118Chapter 7entirely justified, for
- Page 134 and 135: 122Chapter 765. Glaser AW, Davies K
- Page 137 and 138: GENERAL DISCUSSION:A GUIDED TOURPRO
- Page 139 and 140: General Discussion: A Guided Tour P
- Page 141 and 142: General Discussion: A Guided Tour P
- Page 143 and 144: General Discussion: A Guided Tour P
- Page 145 and 146: General Discussion: A Guided Tour P
- Page 147 and 148: General Discussion: A Guided Tour P
- Page 149 and 150: General Discussion: A Guided Tour P
- Page 151: General Discussion: A Guided Tour P
- Page 154 and 155: 142GlossaryCharge (or: tariff)A pri
- Page 156 and 157: 144Glossaryefficient one. We are th
- Page 159 and 160: SUMMARY
- Page 161 and 162: Summary 149mortality. Finally, it i
- Page 163 and 164: Summary 151neonatal surgery. It is
- Page 165 and 166: SAMENVATTING
- Page 167 and 168: Samenvatting 155zoals directe niet-
- Page 169 and 170: Samenvatting 157Hoofdstuk 6 gaat ve
- Page 171: Samenvatting 159vereisen, waarvoor
- Page 174 and 175: 162AcknowledgmentsAlthough I am ind
- Page 176: About the AuthorBorn in De Meern (N